• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NasdaqGS
    427.64 Up 3.85(0.91%) 4:00PM EST
    |After Hours : 428.20 Up 0.56 (0.13%) 6:27PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 2,104,745   1,378,477   445,824  
    Cost of Revenue155,355  84,455  4,216  
    Gross Profit 1,949,390   1,294,022   441,608  
    Operating Expenses
    Research Development859,947  625,554  529,506  
    Selling General and Administrative329,415  210,755  117,261  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 760,028   457,713   (205,159)
    Income from Continuing Operations
    Total Other Income/Expenses Net(231)2,012  3,549  
    Earnings Before Interest And Taxes759,797  459,725  (201,610)
    Interest Expense46,437  45,304  21,282  
    Income Before Tax713,360  414,421  (222,892)
    Income Tax Expense288,998  (335,848)(1,132)
    Minority Interest -   -   -  
    Net Income From Continuing Ops424,362  750,269  (221,760)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 424,362   750,269   (221,760)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 424,362   750,269   (221,760)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.